Application of dried blood spots to determine vitamin D status in a large nutritional study with unsupervised sampling: the Food4Me project by Hoeller U et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License 
 
 
Newcastle University ePrints - eprint.ncl.ac.uk 
 
Hoeller U, Baur M, Roos FF, Brennan L, Daniel H, Fallaize R, Forster H, Gibney 
ER, Gibney M, Godlewska M, Hartwig K, Kolossa S, Lambrinou CP, Livingstone 
KM, Lovegrove JA, Macready AL, Manios Y, Marsaux CFM, Martinez JA, Celis-
Morales C, Moschonis G, Navas-Carretero S, O'Donovan CB, San-Cristobal R, 
Saris WHM, Surwillo A, Traczyk I, Tsirigoti L, Walsh MC, Woolhead C, Mathers 
JC, Weber P, Food4Me Project. 
Application of dried blood spots to determine vitamin D status in a large 
nutritional study with unsupervised sampling: the Food4Me project. 
British Journal of Nutrition 2016, 115(2), 202-211 
Copyright: 
This is the authors accepted manuscript of an article that has been published in its final definitive 
form by Cambridge University Press, 2016  
DOI link to article: 
http://dx.doi.org/10.1017/S0007114515004298 
Date deposited:   
13/04/2016 
Embargo release date: 
09 May 2016  
Page 1 of 26 
 
Application of Dried Blood Spots to determine vitamin D status in a large nutritional study 1 
with unsupervised sampling: the Food4Me project 2 
 3 
Authors: 4 
 5 
Ulrich Hoeller(a)*, Manuela Baur(a), Franz F Roos(a), Lorraine Brennan(c), Hannelore Daniel(g), 6 
Rosalind Fallaize(e), Hannah Forster(c), Eileen R Gibney(c), Mike Gibney(c), Magdalena 7 
Godlewska(i), Kai Hartwig(g), Silvia Kolossa(g), Christina P Lambrinou(h), Katherine M 8 
Livingstone(b), Julie A Lovegrove(e), Anna L Macready(e), Yannis Manios(h), Cyril F M Marsaux(d), 9 
J Alfredo Martinez(f), Carlos Celis-Morales(b), George Moschonis(h), Santiago F Navas-10 
Carretero(f), Clare B O’Donovan(c), Rodrigo San-Cristobal(f), Wim H M Saris(d), Agnieszka 11 
Surwiųųo(i), Iwona Traczyk(i), Lydia Tsirigoti(h), Marianne C Walsh(c), Clara Woolhead(c), John C 12 
Mathers(b), Peter Weber(a) on behalf of the Food4Me project. 13 
 14 
Author affiliations 15 
(a) DSM Nutritional Products, Analytical Research Centre and Human Nutrition & 16 
Health, Basel, Switzerland 17 
(b) Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle 18 
University, Newcastle Upon Tyne, UK.  19 
(c) UCD Institute of Food and Health, University College Dublin, Belfield, Dublin 4, 20 
Republic of Ireland  21 
(d) Department of Human Biology, NUTRIM School of Nutrition and Translational 22 
Research in Metabolism, Maastricht University Medical Centre, Maastricht, The 23 
Netherlands  24 
(e) Hugh Sinclair Unit of Human Nutrition and Institute for Cardiovascular and Metabolic 25 
Research, University of Reading, Reading, UK.  26 
(f) Department of Nutrition, Food Science and Physiology, University of Navarra; CIBER 27 
Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain 28 
(SN-C & JAM) 29 
Page 2 of 26 
 
(g) ZIEL Research Center of Nutrition and Food Sciences, Biochemistry Unit, Technische 30 
Universität München, Germany.  31 
(h) Department of Nutrition and Dietetics, Harokopio University, Athens, Greece.  32 
(i) National Food & Nutrition Institute (IZZ), Warsaw, Poland. 33 
* Corresponding author 34 
 35 
  36 
Page 3 of 26 
 
Abstract 37 
 38 
An efficient and robust method to measure vitamin D (25-OH-D3 and 25-OH-D2) in dried 39 
blood spots (DBS) has been developed and applied in the pan-European multi-centre, 40 
internet-based personalized nutrition intervention study Food4Me. The method includes 41 
calibration with blood containing endogenous 25-OH-D3, spotted as DBS and corrected for 42 
haematocrit content. The methodology was validated following international standards. The 43 
performance characteristics did not reach those of the current gold standard LC-MS/MS in 44 
plasma for all parameters, but were found to be very suitable for status level determination 45 
under field conditions. DBS sample quality was very high, and 3778 measurements of 25-46 
OH-D3 were obtained from 1465 participants. The study centre and the season within study 47 
centre were very good predictors of 25-OH-D3 levels (p<0.001 for each case). Seasonal 48 
effects were modelled by fitting a sine function with a minimum 25-OH-D3 level at January 49 
20, and a maximum at July 21. The seasonal amplitude varied from centre to centre. The 50 
largest difference between winter and summer levels was found in Germany and the 51 
smallest in Poland. The model was cross-validated to determine the consistency of the 52 
predictions and the performance of the DBS method. The Pearson correlation between the 53 
measured values and the predicted values was r=0.65 and the standard deviation of their 54 
differences was 21.2 nmol/l. This includes the analytical variation, and the biological 55 
variation within subjects. Overall, DBS obtained by unsupervised sampling of the 56 
participants at home was a viable methodology for obtaining vitamin D status information in 57 
a large nutritional study. 58 
  59 
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 60 
Introduction 61 
Dried blood spotting is a minimally invasive technique to obtain blood samples on cards of 62 
filter paper for biochemical or genetic analysis. A small prick in a fingertip is enough to 63 
produce a drop of blood suitable for sampling. This approach has the advantages of being 64 
considerably less invasive than venous blood sampling, does not require health 65 
professionals and can be performed by most people on themselves after relatively little 66 
training. In addition, if the analyte is stable in dried whole blood, samples can be 67 
transported at room temperature by regular mail. Infrastructure for taking venous blood 68 
samples, separation of plasma, and storage and shipment of frozen samples is no longer 69 
required. In practice, blood sampling can be achieved anywhere and at any time. This offers 70 
significant benefits, especially for nutrient status determination in populations at remote 71 
locations or at home(1,2). 72 
These advantages made the methodology ideal for use in an internet-based intervention, 73 
such as the Food4Me study, where all data were self-reported and biological samples were 74 
collected remotely by the participants(3). To date, the Food4Me study is the largest multi-75 
centre, internet-based personalized nutrition intervention aiming to compare the 76 
effectiveness of three levels of personalized nutrition (based on dietary, phenotypic and 77 
genotypic data) on behavioural changes (diet and physical activity) and health outcomes 78 
(blood metabolites and obesity-related anthropometrics)(3). The DBS technique was first 79 
introduced for diagnosing phenylketonuria in new-borns by measuring whole blood 80 
phenylalanine concentration (4), and has since been applied to multiple metabolites(1,5). A 81 
critical success factor for assessment of many vitamins and other micronutrients in DBS is 82 
their stability on the sampling cards. The compounds need to be stable in the presence of 83 
oxygen at ambient temperature for at least the initial drying time and shipment time to the 84 
laboratory. In the case of the Food4Me study, this period was about one week. Stability can 85 
be increased by adding reagents such as antioxidants to the sampling cards. However, this 86 
approach has limitations due to safety concerns as the impregnated card comes in close 87 
contact with the pricked fingertip. To date, DBS assays reported for micronutrients include 88 
the vitamins A(6,7), B12(8), D(9-13), K(14) and folate(15). However, only the assays for vitamin A 89 
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and D appear to be used frequently. While vitamin A was reported to be somewhat unstable 90 
with a loss of >10% over the first week(16), no stability issues have been reported for vitamin 91 
D (25-hydroxy vitamin D3). One explanation for the particular stability of this vitamin may 92 
be the presence of a specific vitamin D binding protein in blood that, together with serum 93 
albumin, bind >99 % of the circulating 25-hydroxy vitamin D(17,18), thereby stabilizing the 94 
vitamin on the DBS cards. Vitamin D assays based on DBS have been reported by three 95 
independent research groups viz., Eyles et al.(9) and Newman et al.(11) in 2009, and by 96 
Higashi et al. in 2011(12). While all methods focus on 25-hydroxy vitamin D3 (25-OH-D3), 97 
some procedures also include related metabolites, including 25-hydroxy vitamin D2 (25-OH-98 
D2) and 3-epi-25-hydroxy vitamin D3. The main differences between the assays are in the 99 
detection and calibration methods used and the extent of validation data that have been 100 
published. To date, all methods have been based on reversed-phase LC-MS/MS with ESI+ 101 
detection. Eyles and Higashi derivatised the analytes with a nitrogen containing Diels-Alder 102 
reagent (4-phenyl-1,2,4-triazoline-3,5-dione, PTAD) which increases the sensitivity during 103 
MS-detection significantly, but has two drawbacks: it introduces an additional time 104 
consuming step during sample preparation, and the derivatisation leads to formation of two 105 
stereoisomers that complicate chromatography. The method by Newman et al.(11) does not 106 
use analyte derivatisation, but starts with four large punches of filter paper that limit 107 
automated handling in small vials during sample preparation. A later publication from the 108 
same group indicates that the method has been modified and now also includes 109 
derivatisation of the analytes(13). However, this approach requires by far the largest sample 110 
aliquots i.e. four 6 mm diameter punches. 111 
In general, calibration of DBS analysis is difficult due to the absence of blank samples in the 112 
case of endogenous analytes, and the fact that current reference analytics is performed 113 
from plasma or serum samples, not (dried) blood. All existing methods for vitamin D analysis 114 
share a quite tedious calibration approach using spiked samples of blood, vitamin D 115 
depleted blood or plasma for calibration. 116 
Our aim was to develop a novel, quicker assay for 25-OH-D3 and 25-OH-D2 from DBS 117 
without chemical derivatisation to cope with the expected large sample numbers from the 118 
Food4Me study and which might have utility for future large studies and surveys. We 119 
focused particularly on improving the calibration methodology to allow direct comparison of 120 
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the results with published vitamin D status data, which are derived typically from 121 
measurements on plasma. Aspects of method development are reported, together with 122 
method validation and performance data. The Food4Me study did not include venous blood 123 
sampling, which precluded direct comparison of the results obtained from unsupervised 124 
collection of DBS by the participants at home with a reference method. Quality measures 125 
including spot quality and consistency of status levels of each participant measured at each 126 
time point have been assessed. The vitamin D status results were correlated with variables 127 
such as seasonality and research centre, and compared with literature data. 128 
 129 
Materials and methods 130 
Study design and participants(3) 131 
The Food4Me intervention study was designed as a pan-European randomized controlled 132 
trial (RCT) to determine whether providing personalized dietary advice leads to greater 133 
improvements in eating patterns and health outcomes compared with a conventional 134 
population-based general guidelines approach. Seven research centres in seven European 135 
countries participated with more than 220 participants from each centre. DBS samples were 136 
taken and analysed at three time-points: at baseline, and after 3 and 6 months intervention, 137 
respectively. Details of the study design and baseline characteristics of the participants have 138 
been published elsewhere(3). The seven participating study centres were located in Munich 139 
(Germany), Athens (Greece), Dublin (Ireland), Maastricht (The Netherlands), Warsaw 140 
(Poland), Navarra (Spain) and Reading (U.K.), and recruitment was done country-wide. A 141 
total of 5562 participants (65 % females) were screened online over a 12 month period 142 
between August 2012 and August 2013 and consented to participate. Of these, 1607 (28.9%) 143 
were recruited into the RCT. Participants aged 18 to 79 years (mean 39.8, SD 13.1) were 144 
included in the study of whom 60.9% (n= 980) were women and 96.7% were from white-145 
European background. The mean BMI for all participants was 25.5 (SD 5.2) kg/m2 and 44.8% 146 
(n= 721) of participants were overweight or obese (BMI ш 25.0 kg/m2). This study was 147 
conducted according to the guidelines laid down in the Declaration of Helsinki and all 148 
procedures involving human subjects were approved by the ethics committees of the 149 
participating centres. Written or online informed consent was obtained from all participants. 150 
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Further details on study design and participant characteristics can be found in Celis-Morales 151 
et al.(3,19) 152 
 153 
Samples and sampling protocol 154 
Finger-prick blood samples were collected by participants themselves using a collection pack 155 
with two cards, one provided by Vitas Ltd, Oslo, Norway and one by DSM, Kaiseraugst, 156 
Switzerland. Previous to spotting blood, cards for vitamin D analysis (Whatman Protein 157 
Saver 903 Card, GE Healthcare, Westborough, MA) were pre-treated with 1 % of 2,6-di-tert-158 
butyl-4-methylphenol (BHT) dissolved in methanol (MeOH). 30 µl of 1 % BHT in MeOH were 159 
pipetted to each circle on the card and allowed to dry for at least 30 min at room 160 
temperature (RT). These pre-treated cards were packed in an airtight aluminium bag 161 
(Whatman Foil Bags, item no. 10534321, Whatman Inc., Sanford, ME) with a drying agent 162 
(Sorb-it, item no. 10548234, Süd-Chemie, Germany) and stored at room temperature until 163 
use. To help with blood collection, participants had access to an online video demonstration 164 
with written instructions and frequently asked questions in the language of recruitment. For 165 
the finger pricks, 2.0 mm contact-activated lancets (BD Microtainer, Becton, Dickinson and 166 
Company, Franklin Lakes, NJ) were used. Each participant was asked to fill the two dry blood 167 
spot cards each with five spots at each collection time-point. This is the approx. equivalent 168 
of five drops of blood or 250 µl of blood per card. When the 10 blood spots were filled, 169 
participants were instructed to let the cards dry at RT for at least 2 hours, but not longer 170 
than 4 hours, before samples were put back into the aluminium bags and returned by mail 171 
to the corresponding recruiting centre. The centres verified the content of the bags, and 172 
shipped one bag containing the DBS card to DSM (DSM Nutritional Products Ltd. Switzerland) 173 
for measurements of vitamin D (25-OH D2 and 25-OH D3). While the shipments were done 174 
at ambient temperature, the closed bags were stored at the centres and at DSM at nominal 175 
-20°C.  176 
Calibration was done with whole blood received from blood donors of the 177 
“Blutspendezentrum SRK beider Basel” [blood donation centre at Basel hospital], including 178 
haematocrit values for each sample. The calibration samples (n = 15) had a mean 179 
haematocrit content of 44.2 % (range 38.7 - 49.3 %). Donors were 12 females and 3 males 180 
Page 8 of 26 
 
with an average age of 49 years. The calibration samples were prepared as following: blood 181 
aliquots of 50 µl were pipetted onto a card and allowed to dry for 2 - 4 hours at RT, avoiding 182 
exposure to direct sunlight. Cards were then transferred into aluminium foil bags with 183 
desiccant inside and stored in a freezer at nominal -20°C. Calibration samples were used for 184 
3 - 6 months. As quality control, DBS samples with independently determined 25-OH-D3 185 
content were analysed within each analytical run. 186 
 187 
Reagents and instruments 188 
25-Hydroxycholecalciferol monohydrate (25-OH-D3 monohydrate) was from Dr. 189 
Ehrenstorfer, Augsburg, Germany. 25-Hydroxyergocalciferol (25-OH-D2) and sodium dodecyl 190 
sulphate (ш 99 %, SDS) were supplied by Sigma-Aldrich, St. Louis, USA, 26,26,26,27,27,27-191 
hexadeutero-25-hydroxycholecalciferol (25-OH-D3-d6) was supplied by Medical Isotopes, 192 
Pelham, USA, 2,6-di-tert-butyl-4-methylphenol (ш 99 %, BHT), acetonitrile (gradient grade), 193 
formic acid (Suprapur), toluene and methanol (p.a., MeOH) were from Merck, Darmstadt, 194 
Germany, and MS-grade water was prepared on a Milli-Q instrument. Eppendorf tubes were 195 
centrifuged on a 5417R model centrifuge (Vaudaux-Eppendorf, Schönenbuch, Switzerland), 196 
and evaporation was done on a Cyclone (Prolab, Reinach, Switzerland). Analyte separation 197 
was performed on an Agilent 1260 HPLC with auto sampler, two binary pumps and column 198 
oven coupled to an AB Sciex Qtrap 5500 MS/MS-System with APPI source. 199 
 200 
Assay 201 
Sample preparation: 202 
Prior to analysis, the samples were assessed to see if they met the quality criteria (Figure 1): 203 
spot size (circle filled), thoroughly soaked (observed from the back), and one application of 204 
blood (not composed of many small spots). Two punches (inner diameter of 3.175 mm) 205 
were taken out of the card and placed into a 2 ml Eppendorf tube. After adding 100 µl of 206 
0.1 % SDS-solution and 20 µl of internal standard (ISTD, 25,25,25,26,26,26-hexa-deutero-25-207 
OH-D3, 25 ng/ml in methanol) the tubes were shaken at 40°C for 30 min. Then, 400 µl of 208 
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acetonitrile was added and the shaking continued at RT for 5 min (260/min, IKA shaker). 209 
Afterwards, the tubes were centrifuged at 20000 g for 5 min and the supernatant 210 
transferred into a new 2 ml Eppendorf-tube. The solvent was evaporated to dryness under 211 
vacuum (Cyclone) and the residue was reconstituted with 50 µl injection solvent 212 
(methanol/water, 70:30) and transferred into a micro vial for analysis. 213 
Chromatography and detection: 214 
Chromatography was performed on an Ascentis Express C18 column, 7.5 x 2.1 mm, 2.7 µm 215 
with a guard column using the following gradient:  0 min, flow 600 µl/min, 15 % A; 1.8 min, 216 
600 µl/min, 0 % A; 1.9 min, 1000 µl/min, 0 % A; 3.7 min, 1000 µl/min, 0 % A; 3.8 min, 1000 217 
µl/min, 15 % A; 5.8 min, 1000 µl/min, 15 % A; 5.9 min, 600 µl/min, 15 % A; 6.0 min, 600 218 
µl/min, 15 % A. Mobile phase A consisted of water containing 0.05 % formic acid; mobile 219 
phase B consisted of methanol/acetonitrile (80/20, v/v) containing 0.05 % formic acid. 220 
Samples were kept at 10°C, column temperature was 30°C and injection volume was 10 µl. 221 
Dopant for APPI detection was toluene added post-column at 100 µl/min. Typical retention 222 
times were 1.55 min (25-OH-D3 and ISTD) and 1.71 min (25-OH-D2). 223 
Detection was done on an AB Sciex 5500 Qtrap instrument with APPI positive mode and 224 
MRM scan type at unit resolution. 225 
Parameter table: CUR 20; CAD Medium (9); IS 775; TEM 320; GS1 75; GS2 50; EP 10. 226 
25-OH-D3, 383.3 Q1 Mass (Da), 211.3 Q3 Mass (Da), 50 Dwell (msec), 66 DP, 35 CE, 8 CXP; 227 
25-OH-D3 qualifier, 383.3 Q1 Mass (Da), 257.2 Q3 Mass (Da), 50 Dwell (msec), 91 DP, 21 CE, 228 
12 CXP; ISTD 25-OH-D3-d6, 389.3 Q1 Mass (Da), 211.3 Q3 Mass (Da), 50 Dwell (msec), 51 DP, 229 
41 CE ,8 CXP; 25-OH-D2, 395.2 Q1 Mass (Da), 269.2 Q3 Mass (Da), 50 Dwell (msec), 46 DP, 230 
29 CE, 12 CXP; 25-OH-D2 qualifier, 395.2 Q1 Mass (Da), 209.2 Q3 Mass (Da), 50 Dwell (msec), 231 
56 DP, 39 CE, 10 CXP. 232 
Determination of nominal 25-OH-D3 content of calibration samples: 233 
An aliquot of each whole blood sample spotted for calibration was used for preparation of 234 
plasma. The 25-OH-D3 content of this plasma was measured with an established reference 235 
method(20). The haematocrit content of the whole blood used for calibration was measured 236 
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at the blood donation centre. As the haematocrit contents of the study samples were 237 
unknown, an estimated mean value of 40 % was used for calculation. This value was based 238 
on the rounded mean haematocrit content of the samples used for method development 239 
and validation. The following equation was used to normalize the calibration samples 240 
accordingly. 241 
 
60
100 thaematocri
measurednormalised
u  D3)OHc(25D3)OHc(25  242 
c(25-OH-D3)normalized: concentration of 25-OH-D3 (ng/ml plasma) in a calibration sample, 243 
normalized to 40 % haematocrit content 244 
c(25-OH-D3)measured: concentration of 25-OH-D3 (ng/ml plasma) measured with reference 245 
method in plasma samples obtained from whole blood used for calibration 246 
haematocrit: haematocrit value (%) for whole blood sample obtained from 247 
Blutspendezentrum Basel 248 
For study samples, the resulting 25-OH-D3 concentration was then corrected for sex-specific 249 
mean haematocrit values of 41.5 % for female and 46.5 % for male participants by applying 250 
correction factors of 1.026 for female and 1.121 for male. This was based on information on 251 
the sex-specific reference ranges and means obtained from the seven clinical centres 252 
(personal information).  253 
Performance criteria 254 
The method was validated based on the procedures described in the ‘Guideline on 255 
bioanalytical method validation’ of the European Medicines Agency(21) taking into account 256 
specific requirements and recommendations for DBS analysis(22).Selectivity was tested by 257 
comparison of chromatograms from five samples of different donors with and without spike 258 
of either 25-OH-D3-d6 or 25-OH-D3 at 20 ng/ml blood. As the samples contained 259 
endogenous 25-OH-D3, area ratios of qualifier ion m/z [383 / 257] to quantifier ion m/z [383 260 
/ 211] were calculated and used for assessment of the selectivity of the detection of 25-OH-261 
D3. Carry-over was assessed by measuring blank samples after analysis of high content 262 
samples. No significant carry over was observed. Linearity was determined by analysis of 263 
calibration samples according to the method on three different days. Linear regression of 264 
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the analyte peak area ratio (analyte peak area versus internal standard peak area) against 265 
the nominal concentration was calculated. Differences between nominal concentrations and 266 
calculated concentrations were determined and expressed in %. Deviations of the measured 267 
values from nominal values should be ч 20 % and at least 2/3 of the calibration levels at 268 
each day should meet these criteria. As calibration was performed with endogenous 269 
samples, only a limited concentration range could be tested: 32.5 – 120 nmol/l calculated as 270 
plasma concentrations. The lower limit of quantification was set to 25 nmol/l as this 271 
represents the accepted cut off for vitamin D deficiency(23). Accurate determination of lower 272 
concentrations was not within the scope of the study. For assessing accuracy, samples of 273 
five different subjects were analysed. Prior to spotting the whole blood samples, plasma 274 
was separated from a whole blood aliquot of each sample and analysed with a reference 275 
method(24). Nominal DBS concentrations were calculated by correcting the plasma 276 
concentrations with the corresponding haematocrit value (nominal concentration = plasma 277 
concentration x (100 – haematocrit value) / 100). DBS samples from each subject were 278 
analysed in fivefold and compared with the nominal DBS concentration. Mean accuracy was 279 
calculated and reported as percentage of nominal DBS concentration value. As additional 280 
measure for accuracy and of the influence of varying haematocrit values in the calibration 281 
samples, we re-analysed calibration samples of which the 25-OH-D3 concentration values 282 
were assigned previously within a new set of calibration samples with independently 283 
assigned 25-OH-D3 concentration values. The mean haematocrit value of these samples was 284 
42.0 % (range 39.6 - 43.8 %). To determine intra-day precision, the results from samples 285 
prepared for accuracy were used. To estimate inter-day precision, triplicates of each sample 286 
were analysed on 3 different days. Precision was reported as coefficient of variation (CV) of 287 
the measured concentrations. For determination of stability in the auto sampler at 10°C, 288 
extracts of incurred and spiked DSB samples were re-analysed after 60 h. Long-term stability 289 
was tested by storing DBS samples for up to 6 months at nominal -20°C and comparing the 290 
content analysed after the storage with starting values. There was good stability under both 291 
conditions. 292 
 293 
Statistical analysis 294 
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Longitudinal linear mixed models were used to model 25-OH-D3 levels. Limit of detection 295 
values (LOD) in the 25-OH-D3 measurements were replaced by 12.5 nmol/l (four 296 
measurements, 0.1 %) and lower limit of quantitation values (LOQ) were replaced by 16.25 297 
nmol/l 25-OH-D3 (134 measurements, 3.5 %). Sensitivity analyses were carried out assuming 298 
0 nmol/l for LOD and LOQ values, and 25 nmol/l for LOD and LOQ values, respectively. For 299 
the centre with by far the most LOQ values (Dublin), the model fits differed by -4.0 nmol/l in 300 
winter, assuming 0 nmol/l for LOD and LOQ, and +0.2 nmol/l in summer. Assuming 25 301 
nmol/l for LOQ and LOD values the difference was +2.2 nmol/l in the winter and -0.1 nmol/l 302 
in the summer. The absolute deviations for all other centres were ч 2.4 nmol/l in the winter 303 
and ч 0.2 nmol/l in summer.  304 
To model the seasonal variation at the study sites, the study centre and the interaction of 305 
study centre with the functions sin(SampleYear×2×pi) and cos(SampleYear×2×pi) were 306 
included as fixed effects, and the participants as a random effect. The 20th January was 307 
found to be the consensus date across all study centres when the 25-OH-D3 concentrations 308 
reached their nadir. To simplify the subsequent modelling and interpretation, a single 309 
normalized sine function was derived which oscillated between -1.0 when the 25-OH-D3 310 
concentration was at its lowest on the 20th of January and +1.0 when the 25-OH-D3 311 
concentration was at its highest on the 21st of July. It assumes synchronized timing of 312 
seasons across all study centres, but it differentiates mean levels and seasonal amplitudes 313 
by study centre. The function was coded as follows: 314 
StandardizedSeasonalAmplitude=SSA=sin((SampleYear-20/365.25-0.25)×2×ʋ). On the 20th of 315 
each month, this function had the following values: -1.0 in January, -0.9 in February, -0.5 in 316 
March, 0.0 in April, 0.5 in May, 0.9 in June, 1.0 in July, 0.9 in August, 0.5 in September, 0.0 in 317 
October, -0.5 in November, and -0.9 in December. For a sample taken on the 30th of June, 318 
the SampleYear would equal 2013.5, and the resulting SSA would be 0.94. For each 319 
measurement, the corresponding SSA was thus calculated. The final model was then fitted 320 
using centre and the centre-SSA interaction as fixed effects, and participant ID as random 321 
effect (presented in Table 2 and Figure 2). Due to the absence of a gold standard method, 322 
the biological and the analytical variability could not be separated in the present data set. 323 
The overall variation should thus be considered as a highly conservative estimate of the 324 
variation of the analytical method. R statistics software version 3.02 was used for all 325 
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statistical analyses,(25) and within the R statistics software, the function lme() in the package 326 
nlme(26) was used for the mixed model regressions. 327 
 328 
 329 
Results 330 
The assay described here was developed for analysis of the large sample numbers from the 331 
Food4Me study. Calibration was performed with blood samples containing endogenous 332 
analyte content spotted on DBS cards. The nominal 25-OH-D3 concentration of these 333 
calibration samples was determined from plasma obtained from the same samples with an 334 
established reference method, corrected by the measured haematocrit value. Stability trials 335 
showed that these calibration samples could be used for at least 6 months if stored at 336 
nominal -20°C. The current method is equally applicable for determination of 25-OH-D2 but 337 
because substantial concentrations of 25-OH-D2 were not expected in the current study, 338 
method validation focused on 25-OH-D3. An overview of parameters validated and results 339 
are given in Table 1. The re-analysis of calibration samples within an independent calibration 340 
showed a good correlation between the originally assigned 25-OH-D3 concentrations and 341 
the concentrations determined from the independent calibration for these samples (n = 5, R 342 
= 0.97). Overall, the DBS method showed results with slightly larger variations compared 343 
with current reference methodologies but within or close to the acceptance ranges of the 344 
guidelines. This led to specific characteristics of e.g. a rather small linear range of 32.5 - 120 345 
nmol/l with deviation of up to 18 % between measured and nominal values (guideline limit 346 
15%), and precision up to 13-14 % CV for inter- and intra-day. Overall, it was concluded that 347 
the method was suitable for determination of status levels for vitamin D and thus for 348 
application in the Food4Me study. 349 
In total 3778 DBS samples were analysed: 453 from Germany, 560 from Greece, 554 from 350 
Ireland, 634 from The Netherlands, 530 from Poland, 555 from Spain and 492 from the U.K. 351 
From 1003 participants, DBS at three time points could be measured, from 307 participants 352 
two time points could be measured, while for 155 participants only one time point could be 353 
measured. In addition, no samples were received for analysis from 259 participants (19.7 % 354 
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of total cohort who completed the study), and whilst a further 67 samples gave a valid result 355 
for 25-OH-D3 concentration they lacked a sampling date and so could not be included in the 356 
analysis of effects of seasons. Only 80 samples either did not meet the quality criteria or had 357 
insufficient blood spots for analysis of all required parameters, and only five analyses failed 358 
due to technical errors. Overall the quality of the samples was very good, showing that the 359 
methodology is suitable for unsupervised sampling at home following provision of detailed 360 
instructions to the participants including e.g. a video demonstration of the sampling process. 361 
The data for 25-OH-D3 concentration are presented in Figure 2. None of the samples 362 
contained 25-OH-D2 above the LOQ of 25 nmol/l. The seasonality of the 25-OH-D3 status for 363 
the participants of each study centre is clearly visible (p <0.001) with significantly higher 364 
concentrations in summer than in winter (67.1-92.1 vs. 38.0-63.0 nmol/l). Details of the 365 
observed correlations are given in Table 2. Due to the different starting dates, and the 366 
different duration of the study due to recruiting progress in each centre, the coverage of the 367 
annual time period varied between centres, but it usually included the seasonal minimum 368 
and maximum. DBS collection over more than 12 months occurred in only two centres, 369 
Dublin in Ireland and Reading in the U.K. The values for the seasonal minima and maxima of 370 
25-OH-D3 levels varied by country (Figure 2). The largest seasonal changes were observed in 371 
the participants from Germany 92.1 nmol/l in summer vs. 41.9 nmol/l in winter, whereas 372 
the smallest changes were recorded in Poland (67.1 nmol/l vs. 50.4 nmol/l, respectively). 373 
Overall, the highest values were found in late summer (July 21), and the lowest values in 374 
late winter (January 20). This is in good agreement with data from the literature, although 375 
the number of reports from comparable cohorts is limited(27). 376 
To assess the performance of the analytical method and the statistical model, a leave-one-377 
out cross-validation was performed. Only participants for whom all three planned 378 
measurements were available were included in the validation. For each measured value a 379 
prediction was performed by taking into account the site and the season as fixed factors, 380 
and the subject ID as a random factor. The two other measurements for the same 381 
participant were included each time, and the measurement to be predicted was excluded 382 
each time. In the absence of a gold standard, these predicted values were considered as the 383 
most plausible reference values against which the actual measurement values could be 384 
compared. The resulting Pearson correlation between measured and modelled values was 385 
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r=0.65, and the differences between the modelled and measured values had a standard 386 
deviation of 21.2 nmol/l. This variation is attributable both to biological and analytical 387 
variation. 388 
 389 
Discussion 390 
With 3778 valid measurements obtained from 1465 participants, to the best of our 391 
knowledge the Food4Me study is the largest study using DBS samples where the 392 
participants did the sampling themselves at home. Sample preparation was designed to be 393 
as fast and as easy as possible, with the potential to perform all necessary steps in a 394 
multiwell-plate. A crucial step for the whole methodology was the calibration of the assay. 395 
While analysis of 25-OH-D3 from DBS has been applied before, we introduced 396 
improvements including calibration using DBS with endogenous analyte content and 397 
corrected by the haematocrit content of the calibration samples. As 25-OH-D3 is an 398 
endogenous compound, no blank samples of blood were available. In addition, spiking of 399 
blood with 25-OH-D3 was considered to be questionable, as the endogenous analyte is 400 
almost completely protein bound, and conditions to simulate this with spiking were difficult 401 
to achieve. Using blood with endogenous 25-OH-D3 content simplifies the calibration 402 
procedure and makes the methodology more robust as unknowns and calibration samples 403 
consist of the same matrix. As reference values for many micronutrients, including vitamin D, 404 
are typically reported as plasma levels, a conversion from whole blood is needed. This 405 
conversion is based on the haematocrit content that varies from person to person(28). As 406 
was the case in the Food4Me study, this value is often not available for study samples. 407 
Different approaches to circumvent this issue have been proposed(29) which typically require 408 
an additional measurement of a second blood component such as potassium(30), for 409 
normalization, an approach which introduces additional analytical variance. For the current 410 
study, a haematocrit value of 41.5 % was assigned to samples from female subjects and a 411 
value of 46.5 % to samples from male subjects. As the study design did not include the 412 
concurrent sampling of venous blood and the analysis for 25-OH-D3 in the resulting plasma 413 
as a reference, the influence of haematocrit on the accuracy of the results could not be 414 
verified independently. However, we estimated that our assumption introduced a small 415 
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amount of additional variation, perhaps <10 %. I.e., when considering an exemplified normal 416 
range of 36 - 47 % haematocrit for women, a plasma concentration of 50 nmol/l calculated 417 
for a mean of 41.5 % haematocrit could vary between 45.7 and 55.2 nmol/l. The influence of 418 
other factors including spot size and location of punches on vitamin D determination in DBS 419 
have been reported in the literature.(31) Whilst our new method did not reach the accuracy 420 
of the reference analytics of 25-OH-D3 from plasma by LC-MS/MS, the results are 421 
comparable with, or better than, those reported for other DBS-based methods. E.g., 422 
accuracy by recovery was reported in the range of 95.2 - 102.7 % (four concentration 423 
levels)(12) and 80 - 118 % (three levels)(9) and intra-assay precision in the range of 3.2 - 6.9 % 424 
RSD(12), 8 - 13 % RSD(9) and 11 - 13 % RSD (three levels, inter-assay)(11). Overall, the new 425 
method was found to be suitable for status level determination, as indicated by the 426 
performance criteria in comparison with international guidelines. 427 
In the Food4Me study, sampling of the blood from the finger-tip by participants was done 428 
unsupervised. This posed questions of compliance with the sampling protocol, and with 429 
regard to the impact of deviations from the protocol on overall sample quality. We found 430 
that the large majority of blood spots were of very good quality when assessed visually 431 
compared with our quality control criteria. This also suggests that this finger prick approach 432 
to blood collection was well accepted by the participants given the total of acceptable 433 
measurements, and that provision of both written and video instruction ensures that blood 434 
samples can be obtained reliably from untrained participants in large cohort studies across 435 
multiple countries. Quality aspects not assessable by visual inspection include too long or 436 
too short drying times of the blood, and excessive sun or heat exposure of the sample 437 
before it reached the research centre. In addition, the identity of the blood donor could not 438 
be verified independently, although an embedded validation study of 10 % of participants, 439 
which included verification of identity based on genotype provided reassurance on this 440 
question(32). Therefore, the consistency of data points for each individual participant was 441 
used as an indirect quality indicator. The resultant sequential assessment of vitamin D status 442 
from three DBS measurements over 6 months is unique. A rapid increase in vitamin D status 443 
is possible in case of extended sun exposure or the use of high dose supplementation, but a 444 
fast decline is very unlikely because 25-OH-D3 has a half-life of approx. 20 days following 445 
oral administration(33). The demonstrated consistency of consecutive data from the 446 
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individual participants proves the robustness of the methodology, and the suitability of the 447 
DBS approach with unsupervised sampling for status determination of vitamin D3. 448 
As expected, the results for all countries showed a strong seasonality with lowest mean 449 
vitamin D3 status levels observed towards the end of January and highest mean status levels 450 
towards the end of July. While representative data for vitamin D status is available in some 451 
European countries(27), data on seasonality is more limited. For the U.K., lowest level of 452 
vitamin D3 concentrations were reported in February and highest levels in September 453 
during the 2002 - 2004 period(34), with a difference of approx. 35 nmol/l. Furthermore, 454 
reports for Germany (35,36) clearly demonstrate a seasonality with the highest median value 455 
in June and the lowest median value in March with a difference of 23.4 nmol/l for 1998(36). 456 
Although the participants of the current study may not be representative for each country, 457 
our results are comparable with the published data. An in-depth analysis of differences 458 
between countries will be done separately. 459 
Overall, the current investigation provided valuable insight into effects of seasonality of 460 
vitamin D3 status in 1465 participants from seven European countries. The DBS-based 461 
methodology of unsupervised sampling of DBS by the participants at home was found to be 462 
suitable for status determination of 25-OH-D3 in the setting of the large, international 463 
nutritional study Food4Me. This encourages application in future studies, and has the 464 
potential for simultaneous determination of other micronutrients from the same DBS 465 
samples.  466 
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Table 1: Overview of the performance characteristics of the analytical method. Details are 565 
given in the text. 566 
Validation 
parameter 
Procedure Result (representative values) 
Selectivity Analysis of incurred and spiked 
samples 
Interference with 25-OH-D3-d6 ч 0.4 % 
Interference with 25-OH-D3 ч 14.2 % 
(quantifier to qualifier ratio) 
Carry-over Injection of blank after high 
level spiked sample 
Carry-over of 25-OH-D3 ч 1.6 % 
Carry-over of ISTD ч 0.12 % 
Linearity Analysis of incurred samples 32.5 – 120 nmol/l (as plasma 
concentration) 
Deviation measured from nominal value ч 
18 %; R2ш 0.95 
Accuracy Incurred sample compared 
with reference value 
80 – 95 % 
Precision Analysis of incurred sample Intra-day: 5.8 - 13.0 % CV 
Inter-day:  8.4 - 14.0 % CV 
Recovery  Analysis of incurred and spiked 
samples 
74 - 101 % 
Stability auto 
sampler (10°C) 
Comparison with starting 
values 
60 h at 10°C; difference: ч 6.1 % 
Stability long-
term 
Comparison with starting 
values 
6 months at nominal -20°C; difference ч -
14.1 % 
 567 
  568 
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Table 2:1 Association of 25-OH-D3 levels with the predictors "study centre" and "seasonal 569 
amplitude". 570 
Location Predictor 
Coefficient 
[nmol/l] 
Std.Error 
[nmol/l] t-value p 
SeasonalMin 
[nmol/l] 
SeasonalM
ax 
[nmol/l] 
Munich, 
Germany Study centre 67.0 1.5 43.6 
<0.00
1 41.9 92.1 
 
Seasonal 
Amplitude 25.1 1.3 18.8 
<0.00
1   
Athens, 
Greece Study centre 60.7 1.5 39.9 
<0.00
1 45.6 75.8 
 
Seasonal 
Amplitude 15.1 1.3 11.8 
<0.00
1   
Dublin, 
Ireland Study centre 57.1 1.4 40.3 
<0.00
1 38.0 76.1 
 
Seasonal 
Amplitude 19.0 1.3 14.7 
<0.00
1   
Maastricht
, The 
Netherlan
ds Study centre 73.0 1.4 52.3 
<0.00
1 63.0 83.1 
 
Seasonal 
Amplitudet 10.0 1.1 8.9 
<0.00
1   
Warsaw, 
Poland Study centre 58.7 1.5 39.5 
<0.00
1 50.4 67.1 
 
Seasonal 
Amplitude 8.4 1.2 6.7 
<0.00
1   
Navarra, 
Spain Study centre 65.2 1.5 42.2 
<0.00
1 49.9 80.4 
 
Seasonal 
Amplitude 15.2 1.3 11.8 
<0.00
1   
Reading, 
U.K. Study centre 58.2 1.5 38.2 
<0.00
1 42.1 74.2 
 
Seasonal 
Amplitude 16.1 1.4 11.3 
<0.00
1   
  
      571 
  572 
                                                             
1 The study centre and the season per study centre were very good predictors of the 25-OH-
D3 levels. In Dublin for example, the model estimated that the 25-OH-D3 levels oscillate by 
amplitude of ±19.0 nmol/l around a mean of 57.1 nmol/l over the seasons. This translates to 
a minimum of 38.0 nmol/l on the 20th of January, 57.1 nmol/l on the 20th of April, and a 
maximum of 76.1 nmol/l on the 21st of July. 
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 574 
Figure 1: Quality control criteria for dried blood spots from the Food4Me study. A: spot 575 
suitable for analysis. B - D: spots not suitable for analysis due to B: small spot size not filling 576 
the circle, C: multiple application of too small spots, including spots outside the circle, D: 577 
multiple application of small spots and no thorough soaking of the paper (view from the 578 
back). 579 
  580 
A B 
C D 
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 581 
 582 
Figure 2: Individual measurements for 25-OH-D3 by research centre and sampling date, and 583 
seasonal regression by centre. The model included 3711 measurements from 1412 584 
participants. The predictors were the centre and the interaction of each centre with the 585 
standardized seasonal amplitude (SSA). The SSA for this data set is a sinus function reaching 586 
its minimum -1.0 on January 20 and its maximum +1.0 on July 21, as explained in the 587 
statistical methods section. The participant ID was included as random effect. The fixed 588 
effect regression fits are visualized within each plot. The largest seasonal oscillations were 589 
Page 25 of 26 
 
observed in Germany (92.1 nmol/l in summer vs. 41.9 nmol/l in winternM), and the smallest 590 
in Poland (67.1 nmol/l in summer vs. 50.4 nmol/l in winternM). Example calculation: on May 591 
20, the SSA reaches 0.5, therefore the estimate for a participant in Germany would be 592 
67.0+0.5×25.1=79.6nmol/l. Horizontal lines indicate vitamin D status intervals: < 25nM 593 
deficient, 25-50 nM insufficient, 50-75 nM sufficient, > 75 nM optimal range. 594 
  595 
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 597 
Figure 3: Comparison between modelled 25-OH-D3 values and actually measured 25-OH-D3 598 
values, based on a leave-one-out cross-validation of the model in Table 2 and Figure 2. Only 599 
participants for whom all three pre-planned DBS-based measurements were available were 600 
included in the validation. For each measured value a prediction was performed by taking 601 
into account the site and the season as fixed factors, and the subject ID as a random factor. 602 
While the two other measurements of the same participant were included each time, the 603 
measurement to be predicted was excluded each time. The resulting Pearson correlation 604 
between measured and modelled values was r=0.65, and the differences between the 605 
modelled and measured values had a standard deviation of 21.2 nmol/l.  606 
 607 
